Pagas, Cyril .
HRN: 22-17-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
CEFUROXIME 1.5GM (VIAL)
10/28/2023
10/29/2023
IV
1.5gm
Q8
Gravdio Cardiac
Checking Final Appropriateness
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes